A detailed history of Capstone Financial Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Capstone Financial Advisors, Inc. holds 628 shares of LLY stock, worth $538,491. This represents 0.03% of its overall portfolio holdings.

Number of Shares
628
Previous 439 43.05%
Holding current value
$538,491
Previous $255,000 91.37%
% of portfolio
0.03%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $111,925 - $149,740
189 Added 43.05%
628 $488,000
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $1,575 - $1,857
3 Added 0.69%
439 $255,000
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $25,647 - $35,358
-59 Reduced 11.92%
436 $234,000
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $173,616 - $232,145
495 New
495 $232,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $815B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Capstone Financial Advisors, Inc. Portfolio

Follow Capstone Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capstone Financial Advisors, Inc. with notifications on news.